Carnegie Capital Asset Management, LLC Edwards Lifesciences Corp Transaction History
Carnegie Capital Asset Management, LLC
- $3.34 Billion
- Q3 2024
A detailed history of Carnegie Capital Asset Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Carnegie Capital Asset Management, LLC holds 4,220 shares of EW stock, worth $315,698. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,220
Previous 5,620
24.91%
Holding current value
$315,698
Previous $519,000
46.44%
% of portfolio
0.01%
Previous 0.02%
Shares
21 transactions
Others Institutions Holding EW
# of Institutions
1,350Shares Held
457MCall Options Held
9.76MPut Options Held
3.92M-
Vanguard Group Inc Valley Forge, PA62.6MShares$4.68 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.81 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA31.5MShares$2.36 Billion0.37% of portfolio
-
State Street Corp Boston, MA26.3MShares$1.96 Billion0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA13.5MShares$1.01 Billion0.07% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $46.3B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...